Fludarabine - Bayer HealthCare Pharmaceuticals
Alternative Names: 2-F-ara-AMP; 2-Fluoro-ARA-AMP; 2-Fluoroadenine-arabinoside; Beneflur; Fludara; Fludarabine phosphate; NSC 312887Latest Information Update: 05 Nov 2023
At a glance
- Originator Southern Research Institute
- Developer Bayer HealthCare Pharmaceuticals Inc.; Sanofi
- Class Antineoplastics; Arabinonucleosides; Myeloablative agonists; Purine nucleosides; Small molecules
- Mechanism of Action DNA synthesis inhibitors; Immunosuppressants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Marketed Chronic lymphocytic leukaemia; Mantle-cell lymphoma; Non-Hodgkin's lymphoma